Document is current
Any future updates will be listed below
-
Authors
Facchin, Gabriele https://orcid.org/0000-0002-6695-8954
Battista, Marta Lisa https://orcid.org/0009-0007-6602-8021
Olivieri, Jacopo
Pasquale, Raffaella
De Martino, Maria
Lauzzana, Pietro
Petruzzellis, Giuseppe
Geromin, Antonella
Isola, Miriam https://orcid.org/0000-0002-6391-1720
Fanin, Renato
Patriarca, Francesca https://orcid.org/0000-0002-9813-524X
- License Information
-
More Information
Article History
Received: 21 September 2025
Revised: 14 January 2026
Accepted: 25 February 2026
First Online: 9 March 2026
Competing interests
: FP participated in the advisory Board of Menarini, Sanofi, Bristol Meyer Squibb and received lecture honoraria from Johnson & Johnson and Novartis. JO participated in the advisory Board of AbbVie, Kite and Bristol Meyer Squibb. All other authors declared no potential competing interests in relation to this study.
: The study was approved by the Institutional Review Board (IRB) of Department of Medicine (University of Udine) and was conducted in accordance with the Declaration of Helsinki.
